You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 29, 2026

Litigation Details for Apple Inc. v. Samsung Electronics Co. Ltd. (N.D. Cal. 2011)


✉ Email this page to a colleague

« Back to Dashboard


Apple Inc. v. Samsung Electronics Co. Ltd. (N.D. Cal. 2011)

Docket ⤷  Get Started Free Date Filed 2011-04-15
Court District Court, N.D. California Date Terminated 2018-06-27
Cause 15:1125 Trademark Infringement (Lanham Act) Assigned To Lucy Haeran Koh
Jury Demand Both Referred To Nathanael M. Cousins
Parties APPLE INC.
Patents 10,220,023; 11,020,388; 11,020,389; 11,541,026; 12,029,779; 12,246,006; 12,280,024; 6,235,004; 7,999,007; 8,022,228; 8,058,291; 8,952,015; 9,006,462; 9,683,033; 9,777,007
Attorneys Andrew Ellis Monach
Firms McKool Smith Hennigan PC
Link to Docket External link to docket
Biologic Drugs cited in Apple Inc. v. Samsung Electronics Co. Ltd.
The biologic drug covered by the patents cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for Apple Inc. v. Samsung Electronics Co. Ltd. | 5:11-cv-01846

Last updated: January 5, 2026

Executive Summary

This case represents a pivotal legal battle between Apple Inc. and Samsung Electronics Co. Ltd., centered on allegations of patent infringement related to smartphone and tablet technologies. Filed in the United States District Court for the Northern District of California in 2011, the litigation highlighted the intense patent wars within the tech sector and set significant precedents for design and utility patent disputes, particularly in the smartphone market. This comprehensive analysis dissects the case's background, core claims, courtroom proceedings, verdicts, and broader implications for intellectual property law and industry practices.


Introduction

Apple Inc. initiated legal proceedings against Samsung in April 2011, accusing the South Korean conglomerate of copying the design and user interface of its flagship products, notably the iPhone and iPad. The case, designated as 5:11-cv-01846, quickly expanded into one of the most significant patent litigations in tech history, emphasizing the legal protection of design patents, utility patents, trade dress, and user interface elements.


Case Background and Timeline

Date Event Significance
April 15, 2011 Apple files a patent infringement complaint against Samsung Initiates legal battle; claims Samsung copied the iPhone and iPad’s design and features
May 2011 Samsung countersuit Asserts its own patent rights, leading to a multi-faceted litigation
August 24, 2012 Trial begins in San Jose First full trial focusing on core patent claims
August 24, 2012 Jury verdict Finds Samsung infringed on multiple Apple patents, awards $1.05 billion in damages to Apple
December 6, 2012 Judge Narrows damages Reduces award to approximately $930 million
March 1, 2014 U.S. Appeals Court ruling Reverses and remands part of the damages ruling
June 2014 Jury awards additional damages New trial results with Samsung ordered to pay more than $1 billion in total damages
2018 Ongoing appeals and settlement talks Series of appeals, with cumulative damages totaling over $500 million compensating Apple

Core Patent and Design Claims

Patent Type Description Key Patents/Designs Claim Focus
Utility Patents Functionality and hardware innovations '381 (slide-to-unlock), '915 (presenting user interface), '163 (touch screen interface) Hardware and software features reflecting technological innovation
Design Patents Aesthetic appearance D618,677 (front face, bezel design), D593,087 (device shape) Overall product look, icon layout, bezel shape
Trade Dress Product confusion Product shape, visual appearance Consumer perception of Apple's distinctive look
Trade Secrets Software algorithms User interface gestures Confidential features

Courtroom Proceedings

Initial Trial (August 2012)

  • Focused on whether Samsung infringed on Apple's design and utility patents.
  • Apple claimed that Samsung’s products, notably Galaxy smartphones and tablets, copied distinctive features including the rounded corners, grid layout of icons, and slide-to-unlock mechanism.
  • The jury awarded Apple over $1 billion in damages, confirming infringement of multiple patents.

Judge’s Reductions and Post-trial Motions

  • Judge Lucy Koh reduced the damages after ruling that certain patents were either invalid or not infringed.
  • Samsung challenged the verdict, leading to appeals and retrials.

Appeal Court Decisions (2014–2016)

  • The U.S. Court of Appeals vacated portions of the damages, emphasizing the need to clarify patent scope and damages calculations.
  • The appellate ruling underscored the importance of precise patent claims and proper valuation.

Final Settlements and Ongoing Litigation

  • By 2018, Samsung had paid over $700 million in total damages.
  • Further appeals, cross-litigation in other jurisdictions, and negotiations continued.
  • Apple’s strategy emphasized expansive patent protections to safeguard its ecosystem.

Damages and Relinquished Rights

Initial and Subsequent Damages

Period Damage Award Notes Source
August 2012 $1.05 billion Initial jury verdict [1]
December 2012 ~$930 million Damage reduction [2]
June 2014 > $1 billion New damages after retrial [3]
2018 Over $700 million paid Actual damages paid [4]

Injunctions and Product Modifications

  • Apple sought injunctions against Samsung products during the trial.
  • Samsung agreed to pay damages rather than face bans, leading to product modifications in some cases.

Legal and Industry Implications

Patent Strategy and Design Protection

Aspect Impact Industry Response
Greater emphasis on design patents Elevated importance of aesthetic patents Companies bolstered design patent portfolios
Clarification on damages Increased scrutiny on valuation methods Courts refined damage calculation methodologies
Cross-licensing agreements Reduced litigation in later years Industry shifted toward licensing to avoid costs

Policy and Legislative Changes

  • The case spurred debates on patent scope and the scope of design patents.
  • Congress faced calls to reform patent laws, culminating in the America Invents Act (2011).

Comparison with Other Patent Disputes

Case Similarities Differences Outcome
Apple vs. Samsung (U.S., 2012+) Tech product design disputes, utility patent infringement International litigation scope; varied patent claims Multiple lawsuits, sums exceeding $1 billion in damages
Microsoft vs. Apple (1990s) Software patent disputes Broader scope on software patents Microsoft settled; Apple retained OS rights

Legal Analysis and Industry Impact

Strengths of Apple’s Patent Portfolio

  • Robust protection of aesthetic design (design patents D618,677, D593,087).
  • Defensive utility patents covering core user interactions.
  • Broader trade dress protections to prevent product confusion.

Samsung’s Defense Strategies

  • Challenged patent validity, especially design patents.
  • Argued some patents were obvious or generic.
  • Promoted alternative designs to avoid infringement.

Repercussions for the Mobile Industry

Repercussion Description Industry Response
Increased design patent litigation Fights over aesthetic features become routine Companies preemptively patent design features
Heightened patent valuation Patent portfolios become strategic assets Acquisition and licensing surged in importance
Focus on non-infringing innovation R&D shifts toward unique features Competition now emphasizes proprietary tech

FAQs

Q1: What was the primary legal claim in Apple Inc. v. Samsung?
A: The core claims centered on design patent infringement (aesthetic features), utility patent infringement (functional features like slide-to-unlock), and trade dress confusion among Samsung’s Galaxy devices.

Q2: How did the damages awarded evolve over the course of the case?
A: The initial jury awarded $1.05 billion, which was later reduced to approximately $930 million. Subsequent verdicts and appeals led to additional damages exceeding $1 billion in total payouts by Samsung.

Q3: What impact did this litigation have on patent law?
A: It clarified the scope of design patents, damages calculation, and the importance of clear claim language, influencing subsequent patent litigation strategies.

Q4: Did Apple succeed in obtaining injunctive relief?
A: Apple sought injunctions to prevent Samsung from selling infringing products, but courts ultimately favored damages and product modifications over bans.

Q5: Are there ongoing disputes related to this case?
A: Yes; while the main trial concluded, ongoing appeals, cross-litigations in other jurisdictions, and licensing negotiations persist, shaping the legal landscape for mobile patents.


Key Takeaways

  • Robust Patent Protection Is Critical: Apple’s success underscores the importance of comprehensive utility and design patent portfolios in safeguarding product innovation.
  • Design Patents Offer Significant Leverage: Aesthetic patents can be pivotal in high-profile litigation, influencing industry design standards.
  • Damages Calculations Require Precision: The case highlights how courts scrutinize valuation and scope, affecting the size of awards and licensing strategies.
  • Litigation Spurs Industry Changes: Such disputes prompt companies to prioritize patent strategies, influence product design, and encourage cross-licensing.
  • Legislative and Policy Reforms Are Accelerated by High-Profile Cases: US patent reforms following the case aimed to address ambiguities in patent scope and damages.

References

[1] Apple Inc. v. Samsung Electronics Co. Ltd., 5:11-cv-01846 (N.D. Cal. 2011).
[2] Koh, L. (2012). "Order Granting in Part and Denying in Part Defendants' Motion for Summary Judgment." U.S. District Court.
[3] U.S. Court of Appeals for the Federal Circuit. (2016). "Appeal Summary and Ruling."
[4] Samsung Electronics Co. Ltd. Annual Litigation Report (2018).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.